SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...
A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes ...
SAN DIEGO, CA / ACCESS Newswire / January 21, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results